Rouhollah Rohani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Rouhollah Rohani has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Ali Pajouhi
Student Research Committee, Lorestan University of Medical Sciences, Khorramabad, Iran
1 shared publication - Bahar Amiri
Student Research Committee Lorestan University of Medical Sciences Khorramabad Iran
1 shared publication - Mahya Sadat Mohammadi
Pediatric Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences (TUMS), Iran
1 shared publication - Mohammad Shahrooei
Department of Microbiology and Immunology, Clinical and Diagnostic Immunology, KU Leuven, Leuven, Belgium
1 shared publication - Mohammad Vasei
Gene Therapy Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran
1 shared publication - Mohammadreza Modaresi
Pediatric Respiratory and Sleep Medicine Research Center, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran
1 shared publication
Latest Publications
- Open Access
- 19 October 2026
- Published by Elsevier in Respiratory Medicine Case Reports
- Vol. 64
Primary bronchial fibrous histiocytoma mimicking refractory asthma in a child: A fatal case of misdiagnosis and airway obstruction
- 19 October 2026
- Published by Elsevier in Respiratory Medicine Case Reports
- Vol. 64
Open AccessPrimary bronchial fibrous histiocytoma mimicking refractory asthma in a child: A fatal case of misdiagnosis and airway obstruction
- Open Access
- 1 January 2025
- Published by Wiley in Case Reports in Pediatrics
- Vol. 2025 (1) , 9929135
Prolidase Deficiency Presenting With Pulmonary Arteriovenous Malformations and Seizures: Report of Two Cases From Iran
Prolidase deficiency (PD) is a rare autosomal recessive metabolic disorder caused by pathogenic variants in the PEPD gene, which is responsible for making prolidase and collagen resynthesize. It leads to a wide range of clinical symptoms, including skin ulcers, intellectual disability, and recurrent infections. Diagnostics are based on the presence of dipeptides in the urine and prolidase activity in various cells, as well as the detection of the pathogenic variant in the PEPD gene; however, no standard method is currently known for its diagnosis nor for its treatment. Case 1 presents a 17‐year‐old male with dyspnea, cyanosis, and pulmonary arteriovenous malformations (AVMs), an atypical presentation for PD. Case 2, a one‐year‐old female with fever, seizures, productive coughs, erythematous ulcers, and developmental delays, highlights the disease’s broad symptoms. This study widens our understanding of PD, especially for lesser‐known populations, such as the population in Iran. It indicates considering PD in the differential diagnosis of various diseases and also a global collaboration for managing PD. The study also recommends a standard approach to diagnosing PD and a personal management system due to its broad manifestations. In addition, it indicates the need to consider different ethnic and geographical groups in future PD studies to further enhance our understanding of this rare disease.
- 1 January 2025
- Published by Wiley in Case Reports in Pediatrics
- Vol. 2025 (1) , 9929135
Open AccessProlidase Deficiency Presenting With Pulmonary Arteriovenous Malformations and Seizures: Report of Two Cases From Iran
Prolidase deficiency (PD) is a rare autosomal recessive metabolic disorder caused by pathogenic variants in the PEPD gene, which is responsible for making prolidase and collagen resynthesize. It leads to a wide range of clinical symptoms, including skin ulcers, intellectual disability, and recurrent infections. Diagnostics are based on the presence of dipeptides in the urine and prolidase activity in various cells, as well as the detection of the pathogenic variant in the PEPD gene; however, no standard method is currently known for its diagnosis nor for its treatment. Case 1 presents a 17‐year‐old male with dyspnea, cyanosis, and pulmonary arteriovenous malformations (AVMs), an atypical presentation for PD. Case 2, a one‐year‐old female with fever, seizures, productive coughs, erythematous ulcers, and developmental delays, highlights the disease’s broad symptoms. This study widens our understanding of PD, especially for lesser‐known populations, such as the population in Iran. It indicates considering PD in the differential diagnosis of various diseases and also a global collaboration for managing PD. The study also recommends a standard approach to diagnosing PD and a personal management system due to its broad manifestations. In addition, it indicates the need to consider different ethnic and geographical groups in future PD studies to further enhance our understanding of this rare disease.